3-methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diol hydrobromide | 58260-67-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 四氢异喹啉
• 英文名称: 3-methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diol hydrobromide
• 英文别名: 1,2,3,4-tetrahydro-3-methyl-6,7-Isoquinolinediol hydrobromide；3-methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diol;hydrobromide
• CAS: 58260-67-6
• 化学式: BrH*C₁₀H₁₃NO₂
• 分子量: 260.131
• InChiKey: GAIWDGJELQNOBZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.71
• 重原子数：
  14.0
• 可旋转键数：
  0.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  52.49
• 氢给体数：
  3.0
• 氢受体数：
  3.0

反应信息

• 作为反应物：
  描述：

  3-methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diol hydrobromide 、 2-(4-氯苯基)乙基 异硫代氰酸酯 在 三乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 4.0h， 以91%的产率得到N-[2-(4-chlorophenyl)ethyl]-6,7-dihydroxy-3-methyl-3,4-dihydro-1H-isoquinoline-2-carbothioamide
  参考文献：
  名称：

  SAR studies of capsazepinoid bronchodilators. Part 1: The importance of the catechol moiety and aspects of the B-ring structure

  摘要：

  Capsazepine as well as its derivatives and analogues are general inhibitors of constriction of human small airways. From a systematic variation of the capsazepine structure, divided into four regions, SARs were established. This part concerns the catechol moiety of the A-ring as well as the 2,3,4,5-tetrahydro-1H-2-azepine moiety (the B-ring) of capsazepine. It is revealed that a conformational constrain (as a fused ring) is important and that compounds with a six-membered B-ring (as a 1,2,3,4-tetrahydroisoquinoline) in general are more potent than the corresponding isoindoline, 2,3,4,5 -tetrahydro-1H-2-benzazepi ne and 2,3,4,5-tetrahydro-1H-3-benzazepine derivatives. (C) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2007.11.055
• 作为产物：
  描述：

  6,7-二甲氧基-3-甲基-1,2,3,4-四氢异喹啉 在 氢溴酸 作用下， 反应 5.0h， 以100%的产率得到3-methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diol hydrobromide
  参考文献：
  名称：

  SAR studies of capsazepinoid bronchodilators. Part 1: The importance of the catechol moiety and aspects of the B-ring structure

  摘要：

  Capsazepine as well as its derivatives and analogues are general inhibitors of constriction of human small airways. From a systematic variation of the capsazepine structure, divided into four regions, SARs were established. This part concerns the catechol moiety of the A-ring as well as the 2,3,4,5-tetrahydro-1H-2-azepine moiety (the B-ring) of capsazepine. It is revealed that a conformational constrain (as a fused ring) is important and that compounds with a six-membered B-ring (as a 1,2,3,4-tetrahydroisoquinoline) in general are more potent than the corresponding isoindoline, 2,3,4,5 -tetrahydro-1H-2-benzazepi ne and 2,3,4,5-tetrahydro-1H-3-benzazepine derivatives. (C) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2007.11.055